Valuation: UCB

Market Cap 46.26B 52.6B 42.97B 39.52B 74.12B 5,093B 75.45B 514B 200B 2,484B 197B 193B 8,619B P/E 2026 *
26x
P/E 2027 * 20.7x
Enterprise Value 46.02B 52.32B 42.75B 39.32B 73.73B 5,067B 75.05B 511B 199B 2,471B 196B 192B 8,574B EV / Sales 2026 *
5.39x
EV / Sales 2027 * 4.56x
Free-Float
61.59%
Yield 2026 *
0.6%
Yield 2027 * 0.62%
1 day-0.12%
1 week+3.10%
Current month-7.25%
1 month-1.86%
3 months-0.04%
6 months-6.14%
Current year+1.84%
1 week 234.7
Extreme 234.7
245.3
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 177.6
Extreme 177.6
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Buy

Director

500 0.0003%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%+3.10%+40.83%+196.27% 52.86B
-1.70%-3.94%+13.95%-10.30% 66.25B
+0.51%+37.90%+37.90%+37.90% 43.01B
-1.86%-4.93%-56.15%-56.66% 39.52B
+3.84%-3.92%+53.25%-27.53% 29.19B
-2.92%-0.02%+64.98%+83.78% 23.13B
-2.30%-9.81%+64.28%-53.70% 23.04B
-1.30%-6.18%+3.94%+177.59% 20.48B
-1.04%-1.59%+66.57%+124.27% 16.6B
+0.58%+3.02%+79.09%+148.86% 16.2B
Average -0.43%-1.90%+36.86%+62.05% 33.03B
Weighted average by Cap. -0.56%-1.51%+28.76%+51.75%

Financials

2026 *2027 *
Net sales 8.54B 9.71B 7.94B 7.3B 13.69B 941B 13.93B 94.91B 37.02B 459B 36.47B 35.68B 1,592B 9.64B 10.96B 8.96B 8.24B 15.45B 1,062B 15.73B 107B 41.79B 518B 41.16B 40.27B 1,797B
Net income 1.77B 2.01B 1.64B 1.51B 2.84B 195B 2.89B 19.66B 7.67B 95.06B 7.56B 7.39B 330B 2.28B 2.59B 2.12B 1.95B 3.65B 251B 3.71B 25.3B 9.87B 122B 9.72B 9.51B 424B
Net Debt -242M -275M -225M -207M -388M -26.67B -395M -2.69B -1.05B -13.01B -1.03B -1.01B -45.13B -2.32B -2.64B -2.16B -1.99B -3.72B -256B -3.79B -25.81B -10.07B -125B -9.92B -9.7B -433B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-23 243.00 -0.12% 205,984
26-07-22 €243.30 -0.25% 107,748
26-07-21 €243.90 +2.48% 198,029
26-07-20 €238.00 -0.54% 155,998
26-07-17 €239.30 +0.67% 93,109
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
243.30EUR
Average target price
287.95EUR
Spread / Average Target
+18.35%

Quarterly revenue - Rate of surprise